Changes in Coronary Physiology by μFR Measurement After DREAMS-3G-Scaffold Implantation

JACC Adv. 2025 Aug;4(8):101944. doi: 10.1016/j.jacadv.2025.101944. Epub 2025 Jul 4.

¹ Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA. Electronic address: hector.m.garciagarcia@medstar.net.
² Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
³ Department of Cardiology, Miedziowe Centrum Zdrowia SA, Lubin, Poland; Department of Interventional Cardiology, OLVG, Amsterdam, The Netherlands.
⁴ Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland.
⁵ Division of Cardiology, Cardiovascular Center Oberallgäu-Kempten, Kempten, Germany.
⁶ Department of Cardiology, Ziekenhuis Oost Limburg (ZOL), Genk, Belgium.
⁷ Division of Cardiology, Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain.
⁸ Cardiology Division, University Hospital of Geneva, Geneva, Switzerland.
⁹ Medical Clinic I, Rheinland Klinikum Neuss GmbH, Lukaskrankenhaus, Neuss, Germany.

Abstract

[Figure: see text]

Keywords: DREAMS 3G scaffold; bioresorbable stents; coronary physiology; late lumen loss; μFR.